Antibodies against SARS-CoV-2 in children and adolescents: a one-year longitudinal study
This study demonstrated that most subjects presented antibody response against SARS-CoV-2 over 1 year of follow-up, even if they had asymptomatic infection or comorbidities, including patients with immunosuppression. There was a difference in the magnitude and duration of antibody response, lower in patients with comorbidities and longer and higher in subjects who had severe COVID-19 clinical presentation.
Authors
- Isis Maria Quezado Magalhães
- Valdenize Tiziani (ORCID: https://orcid.org/0000-0001-6783-9212)
- Ricardo Camargo (ORCID: https://orcid.org/0000-0003-0592-8396)
- Elisa de Carvalho (ORCID: https://orcid.org/0000-0002-5079-5011)
- Cristiane Feitosa Salviano (ORCID: https://orcid.org/0000-0002-0221-6011)
- Agenor de Castro Moreira dos Santos Júnior (ORCID: https://orcid.org/0000-0001-8485-2603)
- Luciana de Freitas Velloso Monte (ORCID: https://orcid.org/0000-0001-5595-351X)
- Ana Luiza Rosa Diniz (ORCID: https://orcid.org/0000-0001-5537-9335)
Institutions
- Universidade Católica de Brasília (BR)
- Hospital de Base (BR)
- Hospital Universitário de Brasília (BR)
Publication Details
- Journal
- BMJ Paediatrics Open
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1136/bmjpo-2025-003392
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00